NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Gliknik Inc

Gliknik Inc

Private
Baltimore, MarylandHealthcare & Life Scienceshttps://www.gliknik.com/

Last Round

Early Funding

Jul 7, 2023

Total Funding Raised

$68.89M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Gliknik Inc is a biopharmaceutical company that discovers and develops innovative biologics for the treatment of cancer and autoimmune diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticalmonoclonal antibodiesdrug discoverybispecific antibodyimmune-modulating therapybiotechantibody engineeringclinical-stage biotechautoimmune disease treatmentcancer therapeuticslicensing partnershipbiologicsr&d pipelinemilestone payments

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Gliknik Inc Comparables

Compare Gliknik Inc with similar companies based on industry and business-model similarity.

Gliknik Inc comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Lyvgen Biopharma
78%
Alligator Bioscience
77%
Biond Biologics
77%

Gliknik Inc Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingJul 7, 2023
Series CJun 24, 2021
Corporate FundingFeb 19, 2019
Corporate FundingSep 30, 2013
Series BOct 8, 2012
Grant
Oct 3, 2011

Gliknik Inc Investors

Notable investors and investment history

Gliknik Inc investors
InvestorRounds
William Harris InvestorsSeries A
National Cancer InstituteGrant
Baxter VenturesSeries B
RDA VenturesSeries A, Series C
First InSeries C
LifeTech Developments FundSeries B
PfizerCorporate Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 12, 2026

    Monthly visitors increased 41% MoM, reaching 1.1K.

  • Apr 16, 2026

    Monthly visitors grew 63% MoM.

Gliknik Inc Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Gliknik Inc Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Gliknik Inc's valuation, stock price, and market status.

Firmographic Details

HeadquartersBaltimore, Maryland
Employee Range4
Year Founded2007
Last FundingJul 7, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.